Hongli Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hongli Lin has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Fang Guo
School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, 999077, Hong Kong, China; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin New Territories, Hong Kong, China
2 shared publications - Linwei Tian
School of Public Health, The University of Hong Kong, Hong Kong SAR, China
2 shared publications Renyue Ji
School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, 999077, Hong Kong, China
2 shared publications- Zheshen Han
School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, 999077, Hong Kong, China
2 shared publications Chao Jiang
School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 7 Sassoon Road, Hong Kong, China
1 shared publication- Chao Xie
Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University , Shanghai 200433
1 shared publication
Latest Publications
- Open Access
- 6 January 2026
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 309, 119604
Shared mineral pathology in malignant and non-malignant lung tissues of non-smoking women from Xuan Wei, China
- 6 January 2026
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 309, 119604
Open AccessShared mineral pathology in malignant and non-malignant lung tissues of non-smoking women from Xuan Wei, China
- Open Access
- 16 December 2025
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 501, 140844
Acicular berthierine-chamosite in coal and lung cancer tissues of Xuan Wei, China
- 16 December 2025
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 501, 140844
Open AccessAcicular berthierine-chamosite in coal and lung cancer tissues of Xuan Wei, China
- Open Access
- 28 October 2025
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 23 (5)
Genome-wide Association Studies of over 30,000 Samples with Bone Mineral Density at Multiple Skeletal Sites and Its Clinical Relevance
The ultimate goal of a genome-wide association study (GWAS) is to translate its discoveries into clinical practice. To explore the clinical use of GWAS findings in the bone field, we conducted a GWAS of dual-energy X-ray absorptiometry (DXA)-derived bone mineral density (BMD) traits at 11 skeletal sites, within over 30,000 European individuals from the UK Biobank. A total of 91 unique and independent loci were identified for 11 DXA-derived BMD traits and fractures, including 5 novel loci (harboring the genes ABCA1, CHSY1, CYP24A1, SWAP70, and PAX1) for 6 BMD traits. These loci exhibited evidence of association in both males and females, which could serve as independent replication. We demonstrated that each polygenic risk score (PRS) was independently associated with fracture risk. Although incorporating multiple PRSs (i.e., metaPRS) with clinical risk factors from the Fracture Risk Assessment Tool (FRAX) yielded the highest predictive performance, the improvement was modest in fracture prediction. Additionally, we uncovered genetic correlation and shared polygenicity between head BMD and intracranial aneurysm (IA). Finally, by integrating gene expression and GWAS datasets, we prioritized genes (e.g., ESR1 and SREBF1) encoding druggable human proteins along with their respective inhibitors/antagonists. In conclusion, this comprehensive investigation reveals a new genetic basis for BMD and its clinical relevance to fracture prediction. More importantly, it suggests that head BMD is genetically correlated with IA. The prioritization of genetically supported targets implies the potential repurposing of drugs [e.g., omega-3 polyunsaturated fatty acid (PUFA) supplements] for the prevention of osteoporosis.
- 28 October 2025
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 23 (5)
Open AccessGenome-wide Association Studies of over 30,000 Samples with Bone Mineral Density at Multiple Skeletal Sites and Its Clinical Relevance
The ultimate goal of a genome-wide association study (GWAS) is to translate its discoveries into clinical practice. To explore the clinical use of GWAS findings in the bone field, we conducted a GWAS of dual-energy X-ray absorptiometry (DXA)-derived bone mineral density (BMD) traits at 11 skeletal sites, within over 30,000 European individuals from the UK Biobank. A total of 91 unique and independent loci were identified for 11 DXA-derived BMD traits and fractures, including 5 novel loci (harboring the genes ABCA1, CHSY1, CYP24A1, SWAP70, and PAX1) for 6 BMD traits. These loci exhibited evidence of association in both males and females, which could serve as independent replication. We demonstrated that each polygenic risk score (PRS) was independently associated with fracture risk. Although incorporating multiple PRSs (i.e., metaPRS) with clinical risk factors from the Fracture Risk Assessment Tool (FRAX) yielded the highest predictive performance, the improvement was modest in fracture prediction. Additionally, we uncovered genetic correlation and shared polygenicity between head BMD and intracranial aneurysm (IA). Finally, by integrating gene expression and GWAS datasets, we prioritized genes (e.g., ESR1 and SREBF1) encoding druggable human proteins along with their respective inhibitors/antagonists. In conclusion, this comprehensive investigation reveals a new genetic basis for BMD and its clinical relevance to fracture prediction. More importantly, it suggests that head BMD is genetically correlated with IA. The prioritization of genetically supported targets implies the potential repurposing of drugs [e.g., omega-3 polyunsaturated fatty acid (PUFA) supplements] for the prevention of osteoporosis.